EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CSF neurofilament light chain predicts 10-year clinical and radiologic worsening in multiple sclerosis

Alok Bhan iD, Cecilie Jacobsen iD, Ingvild Dalen, Niels Bergsland iD, Robert Zivadinov, Guido Alves, Kjell-Morten Myhr, Elisabeth Farbu

Multiple Sclerosis Journal - Experimental, Translational and Clinical · 2021-10 · 7 (4)

DOI: 10.1177/20552173211060337 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Multiple Sclerosis Journal - Experimental, Translational and Clinical, online erschienen am 06.12.2021. Verfasst von Alok Bhan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Neuroscience Research Group, Department of Neurology, Stavanger University Hospital, Stavanger, Norway. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Neurofilament light chain (NfL) is an attractive biomarker of disease activity and progression in MS, but there is a lack in long-term prognostic data.

Objective

To test the long-term clinical and radiological prognostic value of cerebrospinal fluid (CSF)-NfL among newly diagnosed patients with MS.

Methods

Newly diagnosed MS patients where followed prospectively with baseline CSF-NfL and repeated MRI and clinical assessments for up to 10 years. Associations between baseline CSF-NfL and longitudinal MRI and clinical assessments were found by Generalized Estimating Equations analysis.

Results

Forty-two participants were included. CSF-NfL at baseline was significantly associated with the rate of atrophy in globus pallidus ( p = 0.009) and hippocampus ( p = 0.001) as evaluated by MRI. Baseline volumes of thalamus (β −0.33; 95% CI −0.57 to −0.10, p = 0.006), T1 (β 0.28; 95% CI 0.11 to 0.44, p = 0.001) and T2 (β 0.16; 95% CI 0.04 to 0.27, p = 0.008) lesions and baseline levels of CSF-NfL (β 0.9; 95% CI 0.3 to 1.5, p = 0.002) significantly predicted EDSS worsening over 10 years. Baseline CSF-NfL gave a comparable prediction to the best MRI volumetric predictors.

Conclusion

CSF-NfL predicted the clinical and radiological course of newly diagnosed patients with MS over a 10-year period, underlining its prognostic role.

Schlagwörter

Stichwörter der Autor:innen

CSFMRIMultiple sclerosisbiomarkerslong-termlongitudinalneurofilamentsprognosis

Autor:innen und Institutionen

  • Neuroscience Research Group, Department of Neurology, Stavanger University Hospital, Stavanger, Norway.
  • Department of Clinical Medicine, University of Bergen, Bergen, Norway.
  • Buffalo Neuroimaging Analysis Center, Department of Neurology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, USA.

ORCID-Profile: Alok Bhan, Cecilie Jacobsen, Niels Bergsland

Zitieren

APA

Bhan, A., Jacobsen, C., Dalen, I., Bergsland, N., Zivadinov, R., Alves, G., Myhr, K. M., & Farbu, E. (2021). CSF neurofilament light chain predicts 10-year clinical and radiologic worsening in multiple sclerosis. Multiple Sclerosis Journal - Experimental, Translational and Clinical, 7(4). https://doi.org/10.1177/20552173211060337

Vancouver

Bhan A, Jacobsen C, Dalen I, Bergsland N, Zivadinov R, Alves G, et al. CSF neurofilament light chain predicts 10-year clinical and radiologic worsening in multiple sclerosis. Multiple Sclerosis Journal - Experimental, Translational and Clinical. 2021;7(4). doi:10.1177/20552173211060337

BibTeX
@article{Bhan2021,
  author = {Bhan, Alok and Jacobsen, Cecilie and Dalen, Ingvild and Bergsland, Niels and Zivadinov, Robert and Alves, Guido and Myhr, Kjell-Morten and Farbu, Elisabeth},
  title = {CSF neurofilament light chain predicts 10-year clinical and radiologic worsening in multiple sclerosis},
  journal = {Multiple Sclerosis Journal - Experimental, Translational and Clinical},
  year = {2021},
  volume = {7},
  number = {4},
  doi = {10.1177/20552173211060337}
}
Kostenlos starten →